🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The study compares the effect of Budesonide, Bismuth and fiber in patients ...
Status
Terminated
Location
Aust-Agder Sentralsjukehus
Start Date
2001-11
Trial ID
NCT00184171
Treatments Being Tested
The goal of this phase 0 proof-of concept study is to measure the therapeut...
Status
Unknown
Location
Division of Nuclear Medicine, University Hospital Basel
Start Date
2023-03-28
Trial ID
NCT05359146
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
The purpose of this study was to evaluate the efficacy and safety of the tr...
Status
Completed
Location
Xijing Hosipital of Digestive Disease
Start Date
2024-09-20
Trial ID
NCT06514274
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
Background: The disease follicular lymphoma (FL) develops when the body ma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-22
Trial ID
NCT03789240
This study aims to show that antiidiotypic sdAb are a new, sensitive, speci...
Status
Completed
Location
UZ Brussel
Start Date
2019-02-12
Trial ID
NCT03956615
Treatments Being Tested
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308